Modalities for the removal of β2-microglobulin from blood

Guillermo A. Ameer*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


The long-term accumulation of β2-microglobulin (β2M) in patients with kidney failure results in a debilitating condition referred to as dialysis-related amyloidosis (DRA). There have been few methods specifically designed to remove the large quantities of β2M that are produced by the body. This article briefly reviews current modalities and concepts for the removal of β2M from blood. The various approaches are classified according to the mechanism of β2M clearance. The potential application of immunoadsorption, a biologically specific approach to remove macromolecules, in the treatment and understanding of DRA is discussed.

Original languageEnglish (US)
Pages (from-to)103-106
Number of pages4
JournalSeminars in Dialysis
Issue number2
StatePublished - 2001

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'Modalities for the removal of β2-microglobulin from blood'. Together they form a unique fingerprint.

Cite this